These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15997009)

  • 1. Herb-drug interaction implications in pediatric practice: an overview of pharmacokinetic trials.
    Johnston BC; Wu P; Mills E
    Arch Pediatr Adolesc Med; 2005 Jul; 159(7):692. PubMed ID: 15997009
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimal sampling theory: An overview of its application to pharmacokinetic studies in infants and children.
    Reed MD
    Pediatrics; 1999 Sep; 104(3 Pt 2):627-32. PubMed ID: 10469805
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical trials in pediatrics: The drug delivery dimension.
    Osuntokun B
    Adv Drug Deliv Rev; 2006 Apr; 58(1):90-105. PubMed ID: 16529842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complementary and alternative medicine use among individuals participating in research: implications for research and practice.
    Welder GJ; Wessel TR; Arant CB; Schofield RS; Zineh I
    Pharmacotherapy; 2006 Dec; 26(12):1794-801. PubMed ID: 17125440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescribing medications in pediatrics: concerns regarding FDA approval and pharmacokinetics.
    Novak E; Allen PJ
    Pediatr Nurs; 2007; 33(1):64-70. PubMed ID: 17411005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can positron emission tomography facilitate paediatric drug development?
    Zimmer L
    Fundam Clin Pharmacol; 2008 Dec; 22(6):595-8. PubMed ID: 19049660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse interactions between herbal and dietary substances and prescription medications: a clinical survey.
    Bush TM; Rayburn KS; Holloway SW; Sanchez-Yamamoto DS; Allen BL; Lam T; So BK; Tran de H; Greyber ER; Kantor S; Roth LW
    Altern Ther Health Med; 2007; 13(2):30-5. PubMed ID: 17405676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concise review: Clinical relevance of drug drug and herb drug interactions mediated by the ABC transporter ABCB1 (MDR1, P-glycoprotein).
    Marchetti S; Mazzanti R; Beijnen JH; Schellens JH
    Oncologist; 2007 Aug; 12(8):927-41. PubMed ID: 17766652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical evaluation of drug interactions with Echinacea spp.
    Freeman C; Spelman K
    Mol Nutr Food Res; 2008 Jul; 52(7):789-98. PubMed ID: 18618481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of drugs that interact with herbs in drug development.
    Zhou SF; Zhou ZW; Li CG; Chen X; Yu X; Xue CC; Herington A
    Drug Discov Today; 2007 Aug; 12(15-16):664-73. PubMed ID: 17706549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of St. John's wort extract on indinavir pharmacokinetics in rats: differentiation of intestinal and hepatic impacts.
    Ho YF; Huang DK; Hsueh WC; Lai MY; Yu HY; Tsai TH
    Life Sci; 2009 Aug; 85(7-8):296-302. PubMed ID: 19559714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmaceutical aspects of clinical trials: concepts of pharmacokinetic investigations].
    Czejka M
    Onkologie; 2008; 31 Suppl 2():29-33. PubMed ID: 18487866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo assessment of herb-drug interactions: possible utility of a pharmacogenetic approach?
    Tomlinson B; Hu M; Lee VW
    Mol Nutr Food Res; 2008 Jul; 52(7):799-809. PubMed ID: 18618477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of drugs in pediatrics using K-PD models: perspectives.
    Tod M
    Fundam Clin Pharmacol; 2008 Dec; 22(6):589-94. PubMed ID: 19049659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study on the pharmacokinetics drug-drug interaction potential of Glycyrrhiza uralensis, a traditional Chinese medicine, with lidocaine in rats.
    Tang J; Song X; Zhu M; Zhang J
    Phytother Res; 2009 May; 23(5):603-7. PubMed ID: 19173278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor formulation information in published pediatric drug trials.
    Standing JF; Khaki ZF; Wong IC
    Pediatrics; 2005 Oct; 116(4):e559-62. PubMed ID: 16199684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic and pharmacodynamic study of interaction of Rhodiola rosea SHR-5 extract with warfarin and theophylline in rats.
    Panossian A; Hovhannisyan A; Abrahamyan H; Gabrielyan E; Wikman G
    Phytother Res; 2009 Mar; 23(3):351-7. PubMed ID: 18844284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population approaches in paediatrics.
    Chatelut E
    Fundam Clin Pharmacol; 2008 Dec; 22(6):575-8. PubMed ID: 19049657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conducting clinical trials in pediatrics.
    Macrae D
    Crit Care Med; 2009 Jan; 37(1 Suppl):S136-9. PubMed ID: 19104213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic predictions in children by using the physiologically based pharmacokinetic modelling.
    Bouzom F; Walther B
    Fundam Clin Pharmacol; 2008 Dec; 22(6):579-87. PubMed ID: 19049658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.